Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives

被引：31
|
作者：
Natsuaki, Masahiro [1 ]
Sonoda, Shinjo [1 ]
Yoshioka, Goro [1 ]
Hongo, Hiroshi [1 ]
Kaneko, Tetsuya [1 ]
Kashiyama, Kuninobu [1 ]
Yokoi, Kensuke [1 ]
Hikichi, Yutaka [2 ]
Node, Koichi [1 ]
机构：
[1] Saga Univ Hosp, Dept Cardiovasc Med, 5-1-1 Nabeshima, Saga 8498501, Japan
[2] Saga Med Ctr, Cardiovasc Ctr, Koseikan, Saga, Japan
来源：
CARDIOVASCULAR INTERVENTION AND THERAPEUTICS | 2022年 / 37卷 / 02期
关键词：
Antiplatelet therapy; Antithrombotic therapy; Percutaneous coronary intervention; ELUTING STENT IMPLANTATION; ARTERY-DISEASE; CARDIOVASCULAR EVENTS; ATRIAL-FIBRILLATION; OPTIMAL DURATION; VASCULAR EVENTS; FOCUSED UPDATE; DOUBLE-BLIND; CLOPIDOGREL; ASPIRIN;
D O I：
10.1007/s12928-022-00847-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Antiplatelet therapy after percutaneous coronary intervention (PCI) has been changing in parallel with the development of drug-eluting stents (DES) and antiplatelet agents. The recommendation of dual antiplatelet therapy duration is getting shorter due to the decreased risk of stent thrombosis in new-generation DES, the use of a P2Y(12) inhibitor as a monotherapy, and the increasing prevalence of high bleeding risk patients. Antithrombotic therapy after PCI has also changed due to the introduction of direct oral anticoagulants. Aspirin-free P2Y(12) inhibitor monotherapy is now being evaluated in several prospective studies as a novel strategy of antiplatelet therapy after PCI. This review shows a current status and provides future perspectives for the antiplatelet therapy after PCI.
引用
收藏
页码：255 / 263
页数：9
相关论文
共 50 条
  • [1] Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives
    Masahiro Natsuaki
    Shinjo Sonoda
    Goro Yoshioka
    Hiroshi Hongo
    Tetsuya Kaneko
    Kuninobu Kashiyama
    Kensuke Yokoi
    Yutaka Hikichi
    Koichi Node
    Cardiovascular Intervention and Therapeutics, 2022, 37 : 255 - 263
  • [2] Antiplatelet Therapy After Percutaneous Coronary Intervention
    Natsuaki, Masahiro
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2022, 86 (05) : 741 - 747
  • [3] Antiplatelet therapy after percutaneous coronary intervention
    Angiolillo, Dominick J.
    Galli, Mattia
    Collet, Jean-Philippe
    Kastrati, Adnan
    O'Donoghue, Michelle L.
    EUROINTERVENTION, 2022, 17 (17) : E1371 - E1396
  • [4] Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
    Alkhalil, Mohammad
    Dzavik, Vladimir
    Bhatt, Deepak L.
    Mehran, Roxana
    Mehta, Shamir R.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 277 - 293
  • [5] State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives
    Gargiulo, Giuseppe
    Valgimigli, Marco
    Capodanno, Davide
    Bittl, John A.
    EUROINTERVENTION, 2017, 13 (06) : 717 - 733
  • [6] The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
    Shlofmitz, Evan
    Shlofmitz, Richard
    Lee, Michael S.
    KOREAN CIRCULATION JOURNAL, 2019, 49 (08) : 645 - 656
  • [7] Post percutaneous coronary intervention antiplatelet therapy: Current perceptions, prospects and perplexity
    Pant, Sadip
    Neupane, Pritam
    Ramesh, K. C.
    Barakoti, Murari
    CARDIOLOGY JOURNAL, 2011, 18 (06) : 712 - 717
  • [8] Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention
    Sammut, Mark Anthony
    Storey, Robert F.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2024, 22 (09) : 471 - 482
  • [9] Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents A Systematic Review and Network Meta-Analysis
    Khan, Safi U.
    Singh, Maninder
    Valavoor, Shahul
    Khan, Muhammad U.
    Lone, Ahmad N.
    Khan, Muhammad Zia
    Khan, Muhammad Shahzeb
    Mani, Preethi
    Kapadia, Samir R.
    Michos, Erin D.
    Stone, Gregg W.
    Kalra, Ankur
    Bhatt, Deepak L.
    CIRCULATION, 2020, 142 (15) : 1425 - 1436
  • [10] Antiplatelet therapy for coronary artery disease in 2023: current status and future prospects
    Chandiramani, Rishi
    Spirito, Alessandro
    Johnson, James W.
    Mehta, Adhya
    Vogel, Birgit
    Faillace, Robert T.
    Mehran, Roxana
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (05) : 311 - 328
12345